Recommendations of the national heart, lung, and blood institute working group on cerebrovascular biology and disease

Costantino IADECOLA; Stephen S GOLDMAN; David R HARDER; Donald D HEISTAD; Zvonimir S KATUSIC; Michael A MOSKOWITZ; J Marc Simard; Michael A SLOAN; Richard J TRAYSTMAN; Paul A VELLETRI

doi:10.1161/01.STR.0000221297.57305.8a

Back

Recommendations of the national heart, lung, and blood institute working group on cerebrovascular biology and disease

Journal article

Open access

Peer reviewed

Recommendations of the national heart, lung, and blood institute working group on cerebrovascular biology and disease

Costantino IADECOLA, Stephen S GOLDMAN, David R HARDER, Donald D HEISTAD, Zvonimir S KATUSIC, Michael A MOSKOWITZ, J Marc Simard, Michael A SLOAN, Richard J TRAYSTMAN and Paul A VELLETRI

Stroke (1970), Vol.37(6), pp.1578-1581

2006

DOI: 10.1161/01.STR.0000221297.57305.8a

PMCID: PMC2730969

PMID: 16627792

Files and links (1)

url

https://doi.org/10.1161/01.STR.0000221297.57305.8aView

Published (Version of record) Open Access

Abstract

The National Heart, Lung, and Blood Institute (NHLBI) convened a conference call working group, consisting of experts in stroke and cerebrovascular biology on January 28, 2005. The purpose of this working group was to develop a prioritized set of recommendations for NHLBI to establish a focused and comprehensive set of research activities in cerebrovascular biology and disease. Three thematic areas of research emerged: (1) molecular and cellular neurobiology of cerebral blood vessels, focusing on genomics and proteomics, neurovascular signaling and cerebrovascular embryogenesis, development and plasticity; (2) resource development, involving the development of new methodological approaches for normal and altered function of the neurovascular unit, collaborative research, and training in cerebrovascular pathobiology; and (3) cerebrovascular diseases and translational approaches, addressing vascular mechanisms of disease, the role of risk factors, importance of biomarkers with the ultimate goal of developing new treatments.

Cardiovascular System

Heart

Neurology

Cardiology. Vascular system

Endocardial and cardiac valvular diseases

Pharmacology. Drug treatments

Biological and medical sciences

Vascular diseases and vascular malformations of the nervous system

Medical sciences

Antihypertensive agents

Details

Title: Subtitle: Recommendations of the national heart, lung, and blood institute working group on cerebrovascular biology and disease
Creators: Costantino IADECOLA - Weill Cornell Medical College, New York. NY, United States
Stephen S GOLDMAN - National Heart, Lung, and Blood Institute, Bethesda, MD, United States
David R HARDER - Medical College of Wisconsin, Milwaukee. WI, United States
Donald D HEISTAD - University of Iowa, Iowa City, IA, United States
Zvonimir S KATUSIC - Mayo Clinic College of Medicine, Rochester, MN, United States
Michael A MOSKOWITZ - Massachusetts General Hospital, Charlestown, MA, United States
J Marc Simard - University of Maryland Medical School, Baltimure, MD, United States
Michael A SLOAN - Carolinas Medical Center, Charlotte, NC, United States
Richard J TRAYSTMAN - Oregon Health and Science University School of Medicine, Portland. OR, United States
Paul A VELLETRI - National Heart, Lung, and Blood Institute, Bethesda, MD, United States
Resource Type: Journal article
Publication Details: Stroke (1970), Vol.37(6), pp.1578-1581
Publisher: Lippincott Williams & Wilkins; Hagerstown, MD
DOI: 10.1161/01.STR.0000221297.57305.8a
PMID: 16627792
PMCID: PMC2730969
ISSN: 0039-2499
eISSN: 1524-4628
Language: English
Date published: 2006
Academic Unit: Cardiovascular Medicine; Neuroscience and Pharmacology; Internal Medicine
Record Identifier: 9984040540602771

Metrics

22 Record Views

30 Times Cited - Web of Science